# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-018310
Filing Date
2025-02-28
Accepted
2025-02-28 07:01:17
Documents
25
Period of Report
2025-02-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REPORT OF FOREIGN PRIVATE ISSUER | ea023254701-6k_alterity.htm | 6-K | 14234
2 | NOTICE OF EXTRAORDINARY GENERAL MEETING/PROXY FORM | ea023254701ex99-1_alterity.htm | EX-99.1 | 20493
3 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 374843
4 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 902792
5 | GRAPHIC | ex99-1_003.jpg | GRAPHIC | 895955
6 | GRAPHIC | ex99-1_004.jpg | GRAPHIC | 869142
7 | GRAPHIC | ex99-1_005.jpg | GRAPHIC | 197578
8 | GRAPHIC | ex99-1_006.jpg | GRAPHIC | 828023
9 | GRAPHIC | ex99-1_007.jpg | GRAPHIC | 840366
10 | GRAPHIC | ex99-1_008.jpg | GRAPHIC | 634196
11 | GRAPHIC | ex99-1_009.jpg | GRAPHIC | 865652
12 | GRAPHIC | ex99-1_010.jpg | GRAPHIC | 900255
13 | GRAPHIC | ex99-1_011.jpg | GRAPHIC | 1064203
14 | GRAPHIC | ex99-1_012.jpg | GRAPHIC | 1055799
15 | GRAPHIC | ex99-1_013.jpg | GRAPHIC | 1017938
16 | GRAPHIC | ex99-1_014.jpg | GRAPHIC | 944198
17 | GRAPHIC | ex99-1_015.jpg | GRAPHIC | 866149
18 | GRAPHIC | ex99-1_016.jpg | GRAPHIC | 1069184
19 | GRAPHIC | ex99-1_017.jpg | GRAPHIC | 991259
20 | GRAPHIC | ex99-1_018.jpg | GRAPHIC | 509288
21 | GRAPHIC | ex99-1_019.jpg | GRAPHIC | 1120859
22 | GRAPHIC | ex99-1_020.jpg | GRAPHIC | 588533
23 | GRAPHIC | ex99-1_021.jpg | GRAPHIC | 1049768
24 | GRAPHIC | ex99-1_022.jpg | GRAPHIC | 1002816
25 | GRAPHIC | ex99-1_023.jpg | GRAPHIC | 793967
| Complete submission text file | 0001213900-25-018310.txt |  | 26731638

Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 25682520
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)